Products

Our Products

HLS in Canada is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties.

Product Pipeline

For Canadian Residents looking to access commercial product information, please click on the product name in the table below

CARDIOVASCULAR (CV)
Vascepa CV risk reduction Canada Marketed
Trinomia CV risk reduction Canada Under review
CENTRAL NERVOUS SYSTEM (CNS)
Clozaril Schizophrenia U.S./Canada Marketed
CSAN Pronto WBC Point-of-Care Testing Canada Marketed
PERSERIS Schizophrenia Canada Approved and in pre-launch phase
MyCare Psychiatry Psychiatric Therapeutic Drug Monitoring Canada Marketed
ROYALTY PRODUCTS
Royalty Portfolio Multiple Indications Global Marketed by third parties

For U.S. Residents, click on the American flag above for more commercial product information.